Given its short therapeutic time window, successful ischemic stroke therapy requires a multi-disciplinary and streamlined approach. Intravenous recombinant tissue plasminogen activator remains the most efficacious treatment available. New therapies and advances in the understanding comorbidities associated with stroke have reshaped and expanded traditional treatment.
|Original language||English (US)|
|Number of pages||9|
|State||Published - Jan 1 2009|
ASJC Scopus subject areas